Ariad Pharmaceuticals Inc

Type: Company
Name: Ariad Pharmaceuticals Inc
First reported Jul 24 2014 - Updated Jul 25 2014 - 1 reports

3 Huge Stocks to Trade (or Not)

  BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating investment ideas. Instead, let the crowd do it for you.Read More: 5 Stocks Insiders Love Right NowFrom ... [Published The Street Latest - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 25 2014 - 1 reports

Morning Market Movers

VASCO Data Security International (NASDAQ: VDSI) shares climbed 19.40% to $13.85 after the company reported upbeat quarterly results and issued a strong FY14 revenue forecastLogitech International SA (NASDAQ: LOGI) jumped 16.28% to $15.50 after the company ... [Published Benzinga.com - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 25 2014 - 3 reports

Relatively Good Performance Detected in Shares of Ariad Pharmaceuticals in the Biotechnology Industry (ARIA, KERX, OPK, PCYC, ACAD)

Written on Fri, 07/25/2014 - 8:52amBy David DiazBelow are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the ... [Published Comtex SmarTrend - Jul 25 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Benzinga's M&A Chatter for Wednesday July 23, 2014

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday July 23, 2014: Gas Natural Tells ...Related Stocks:ALIBABA GRP SP ADS Algonquin Power Ariad Pharmaceuticals, Inc. GAS NATURAL, Inc. MACY'S, Inc. NEWSTAR FINANCIAL ... [Published MoneyShow.com - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Benzinga's Top #PreMarket Gainers

Logitech International SA (NASDAQ: LOGI) shares surged 15.75% to $15.43 in pre-market trading after the company reported better-than-expected quarterly results and raised its operating income forecast.Facebook (NASDAQ: FB) shares jumped 9.68% to $78.19 ... [Published Benzinga.com - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Ariad Pharmaceuticals (ARIA) Worth Watching: Stock Gains 15.3%

(ARIA) was a big mover last session with its shares rising over 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company as the stock has lost nearly ... [Published Yahoo! Finance - Jul 24 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 2 reports

Ariad Pharmaceuticals : to Webcast Conference Call on Second Quarter 2014 Financial Results

ARIADPharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it willreport its second quarter 2014 financial results on Wednesday, August 6,2014, before the market opens. Following the announcement, at 8:30 a.m.Eastern Time, company management will ... [Published 4 Traders - Jul 16 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 2 reports

Ariad Stock's Biggest Risk Is Its Only Hope

Overreliance on its blood cancer drug Iclusig (ponatinib) continues to make Ariad Pharmaceuticals (NASDAQ: ARIA After a dramatic FDA recall in 2013 based on a handful of serious adverse events and patient deaths related to an Iclusig clinical trial, it ... [Published Motley Fool - Jul 15 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

Ariad Pharmaceuticals Sees Large Growth in Short Interest (ARIA)

Ariad Pharmaceuticals (NASDAQ:ARIA) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 48,055,172 shares, a growth of 16.0% from the June 13th total of 41,432,857 shares, ... [Published American Banking News - Jul 15 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 3 reports

European panel wants more information about Ariad leukemia drug

Ariad Pharmaceuticals Inc. said Monday that a risk assessment panel of European regulators has asked for more information about Iclusig, the Cambridge company’s drug for certain forms of chronic myeloid leukemia.Iclusig went on the market in Europe a ... [Published Boston Globe - Jul 14 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

Shares of Ariad Pharmaceuticals Receive ...

Up 1.2% to $6.02, Ariad Pharmaceuticals (NASDAQ:ARIA), is one of today's notable movers. The S&P is trading fractionally lower to 1,964 and the Dow is trading fractionally lower to 16,904.ARIAD Pharmaceuticals, Inc. discovers and develops breakthrough ... [Published Financial News Network online - Jul 11 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 2 reports

The Biggest Beneficiary Of Biotech’s Comeback

NASDAQ:GILD, NASDAQ:IDIX, NYSE:MRK Related posts: Biotechs With Big Upside [Gilead Sciences, Inc., Biogen Idec Inc, Alexion Pharmaceuticals, Inc., Celgene Corporation, Novartis AG (ADR)] Hepatitis C and Merck [Merck & Co., Inc., Gilead Sciences, Inc.] ... [Published Crawford Financial Planning - Jul 10 2014]

Quotes

"In some embodiments, the immunogenic composition further comprises an immunostimulatory substance. In some embodiments, the immunostimulatory substance is a Toll-like receptor (TLR) inducer. In certain embodiments the TLR inducer is selected from the group consisting of: a CpG-containing oligonucleotide, an immunostimulatory nucleic acid, a lipopolysaccharide, a peptidoglycan, a lipoteichoic acid, an imidazoquinoline compound, a flagellin, a lipoprotein, and an immunostimulatory organic molecule. In a currently preferred embodiment, the TLR inducer is a CpG-containing oligonucleotide. In some embodiments, the immunogenic composition is administered together with an adjuvant."

More Content

All (216) | News (129) | Reports (0) | Blogs (77) | Audio/Video (0) | Fact Sheets (1) | Press Releases (9)
sort by: Date | Relevance
"Anti-Measles Cancer Immunotherapy" in Patent A... [Published HispanicBusiness.com - 14 hours ago]
Hottest Healthcare Stocks Now – AEGR REGN EXAM EW [Published InvestorPlace.com - Jul 30 2014]
Biggest Movers in Healthcare Stocks Now – UTHR ... [Published InvestorPlace.com - Jul 29 2014]
Hottest Healthcare Stocks Now – HSP UHS LPNT RDY [Published InvestorPlace.com - Jul 28 2014]
FirstWord Lists: Which billion-dollar biotechs ... [Published FirstWord Pharma - Jul 27 2014]
Biggest Movers in Healthcare Stocks Now – UHS L... [Published InvestorPlace.com - Jul 25 2014]
Relatively Good Performance Detected in Shares ... [Published Comtex SmarTrend - Jul 25 2014]
3 Huge Stocks to Trade (or Not) [Published The Street Latest - Jul 24 2014]
Ariad Pharmaceuticals Shares Climbing Hi... [Published Financial News Network online - Jul 24 2014]
Biggest Movers in Healthcare Stocks Now – SPNC ... [Published InvestorPlace.com - Jul 24 2014]
ARIAD Pharmaceuticals (ARIA) Shares Cross Above... [Published Chicago Daily Herald - Jul 24 2014]
Relatively Good Performance Detected in Shares ... [Published Comtex SmarTrend - Jul 24 2014]
Morning Market Movers [Published Benzinga.com - Jul 24 2014]
Best Relative Performance in the Biotechnology ... [Published Comtex SmarTrend - Jul 24 2014]
Pre-Market Most Active for Jul 24, 2014 : FB, N... [Published Nasdaq - Jul 24 2014]
Benzinga's Top #PreMarket Gainers [Published Benzinga.com - Jul 24 2014]
Ariad Pharmaceuticals (ARIA) Worth Watching: St... [Published Yahoo! Finance - Jul 24 2014]
'Fast Money' Recap: Facebook and Analysts' Expe... [Published TheStreet.com - Jul 24 2014]
'Fast Money' Recap: Facebook and Analysts' Expe... [Published The Street Latest - Jul 24 2014]
Benzinga's M&A Chatter for Wednesday July 23, 2014 [Published MoneyShow.com - Jul 24 2014]
Biggest Movers in Healthcare Stocks Now – ARIA ... [Published InvestorPlace.com - Jul 24 2014]
Benzinga's M&A Chatter for Wednesday July 23, 2014 [Published Benzinga.com - Jul 23 2014]
Mixed Session, Getting a Little Long in the Tooth [Published Individual.com - Jul 23 2014]
Ariad Pharmaceuticals Down 13.1% Since SmarTren... [Published Individual.com - Jul 23 2014]
ARIAD PHARMACEUTICALS : Assigned Patent [Published 4 Traders - Jul 18 2014]
EMA Continues Review Of Ariad’s Iclusig In EU [Published Bioresearch Online - Jul 17 2014]
ARIAD PHARMACEUTICALS : Thursday's ETF Movers: ... [Published 4 Traders - Jul 17 2014]
BB BIOTECH AG: Biotech sector recovers from mar... [Published EuroInvestor - Jul 17 2014]
Momentum Stocks Face Another Sell Off [Published Bidness Etc - Jul 16 2014]
Yellen, Icahn Comments Put a Lid on Small-Cap S... [Published Delco Times - Jul 16 2014]
1 2 3 4 5 6 7 8
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
ARIAD to Webcast Conference Call on Second Quar... [Published Business Wire Health News - Jul 16 2014]
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report its second quarter 2014 financial results on Wednesday, August 6, 2014, before the market opens. Following the announcement, at 8:30 a.m. ...
ARIAD Announces Continuation of Iclusig Review ... [Published Business Wire Health News - Jul 14 2014]
CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has provided the Company with a request ...
ARIAD Announces Three Key Appointments to Its G... [Published Business Wire Photo/Multimedia News - Jun 23 2014]
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced the recent appointments of three executives with extensive pharmaceutical industry experience in the areas of global quality, medical affairs, and drug safety ...
ARIAD Announces Three Key Appointments to Its G... [Published Business Wire News with Multimedia - Jun 23 2014]
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced the recent appointments of three executives with extensive pharmaceutical industry experience in the areas of global quality, medical affairs, and drug safety ...
ARIAD Announces Three Key Appointments to Its G... [Published Business Wire Health News - Jun 23 2014]
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced the recent appointments of three executives with extensive pharmaceutical industry experience in the areas of global quality, medical affairs, and drug safety ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Clinical Studies, Trials Results, Appointments,... [Published Financial Services - Jun 27 2014]
Stock Watchout on Biotech Industry -- Research ... [Published Financial Services - Jun 26 2014]
Active Stocks at a Glance -- Research on Americ... [Published Financial Services - May 05 2014]
Clinical Trial Results and Initiation, Endowmen... [Published Financial Services - Apr 11 2014]
Technical Pointers on Top Gainers -- Research o... [Published Financial Services - Mar 31 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.